Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Rubedo Life Sciences Closes $40M Series A

2024-04-22
SUNNYVALE, CA, Rubedo Life Sciences, a biopharmaceutical company announced the closing of a $40M Series A financing round.
Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, announced the closing of a $40M Series A financing round. The round was led by Khosla Ventures and Ahren Innovation Capital, with participation from Hevolution, R42, Modi Ventures, Cerigo Investments, Shanda Group, Refactor Capital, LongeVC, Italian Angels for Growth (IAG), and other investors.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors